Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
2015 · The American Journal of Gastroenterology · 1,784 citations
https://doi.org/10.1038/ajg.2015.233
R
Robert V. Bryant
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
206
Papers
7.8K
Citations
38
h-index
80
i10-index
Robert V. Bryant is an academic researcher from Queen Elizabeth Hospital. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Clostridium difficile and Clostridium perfringens research. The author has an h-index of 38, co-authored 176 publications.
ORCID: 0000-0003-4229-3289Papers by this author
worksECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease
2021 · Journal of Crohn s and Colitis · 118 citations
https://doi.org/10.1093/ecco-jcc/jjab180
NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease
2017 · Mucosal Immunology · 89 citations
https://doi.org/10.1038/mi.2017.74
Conventional drug therapy for inflammatory bowel disease
2014 · Scandinavian Journal of Gastroenterology · 72 citations
https://doi.org/10.3109/00365521.2014.968864
Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients
2019 · EBioMedicine · 72 citations
https://doi.org/10.1016/j.ebiom.2019.03.070
International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement
2024 · The Lancet. Gastroenterology & hepatology · 28 citations
https://doi.org/10.1016/s2468-1253(24)00265-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat